Home
>
US Stocks
>
Vaxart Inc
Vaxart Inc
VXRT

Vaxart Inc (VXRT)

$6.7425.19%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
6.76
Today Low/High
6.41 / 6.76
52 Week Low/High
$3.5 / $24.9
P/E ratio
-18.9898
Market Cap
$1.03B

Company Details

Vaxart is a clinical-stage biotechnology company developing a range of oral recombinant vaccines based on its proprietary delivery platform. Vaxart vaccines are designed to be administered using tablets that can be stored and shipped without refrigeration and eliminate the risk of needle-stick injury. Vaxart has believes that its proprietary tablet vaccine delivery platform is suitable to deliver recombinant vaccines, positioning the company to develop oral versions of currently marketed vaccines and to design recombinant vaccines for new indications. Its development programs currently include tablet vaccines designed to protect against coronavirus, Norovirus, seasonal influenza and respiratory syncytial virus (RSV), as well as a therapeutic vaccine for human papillomavirus (HPV), Vaxart's first immuno-oncology indication. Vaxart has filed broad domestic and international patents covering its proprietary technology and creations for oral vaccination using adenovirus and TLR3 agonists.
Organisation
Vaxart Inc
Employees
28
Industry
Health Technology

Discover more

Frequently Asked Questions

What is Vaxart Inc (VXRT) share price today?

Can Indians buy Vaxart Inc (VXRT) shares?

How can I buy Vaxart Inc (VXRT) shares from India?

Can Fractional shares of Vaxart Inc (VXRT) be purchased?

What are the documents required to start investing in Vaxart Inc (VXRT) stocks?

We are a SEBI registered investement advisor